CN Stock MarketDetailed Quotes

600538 Beihai Gofar Chuanshan Biological

Watchlist
  • 5.36
  • +0.04+0.75%
Market Closed Nov 29 15:00 CST
2.81BMarket Cap-32095P/E (TTM)

About Beihai Gofar Chuanshan Biological Company

The company was founded in 1993 and is an enterprise mainly engaged in the wholesale business. The main industries the company operates include pharmaceutical manufacturing and pharmaceutical distribution industries, judicial IVD (in vitro diagnosis) technical services, molecular medical imaging centers, tumor radiotherapy centers, and oncology telemedicine technical services. The company's main products include “Haibao” brand pearl eye drops, pearl powder, pearl layer powder, gastrointestinal relief granules, ethanol disinfectant, etc. Corporate honors: “Best Practice for Listed Companies 2022 Report Performance Briefing”, National Key New Products, National Key New Products, Beihai Guofa Biopesticides Award Certificate, etc.

Company Profile

Short Name-A国发股份
Symbol-A600538
Company NameBeihai Gofar Chuanshan Biological Co., Ltd.
Listing DateJan 14, 2003
Issue Price6.69
Shares Offered45.00M share(s)
FoundedJan 22, 1993
Listed ExchangeSH Stock Exchange
Legal Representativeyedai jiang
Secretaryyong li
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativeliping li
Legal CounselBeijing Times Jiuhe Law Firm
Employees157
Phone0779-3200619
Office AddressNo. 3 Beibu Bay Middle Road, Beihai City, Guangxi Zhuang Autonomous Region
Zip Code536000
Registered AddressNo. 3 Beibu Bay Middle Road, Beihai City, Guangxi Zhuang Autonomous Region
Fax0779-3200618
Emailsecurities@gofar.com.cn
Websitehttp://www.gofar.com.cn
Business License450500000008877
BusinessLicensed projects: pharmaceutical wholesale; pharmaceutical retail; pharmaceutical production; production of Class II medical devices; production of disinfectants (excluding hazardous chemicals); medical services; real estate development and operation. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments; specific business projects are subject to the approval documents or licenses of the relevant departments). General projects: medical research and experimental development; research and development of marine bioactive substances extraction, purification and synthesis technology; investment activities with own funds; technical services, technology development, technical consulting, technology exchange, technology transfer, technology promotion; non-residential real estate leasing; advertising; sale of arts and crafts and ceremonial goods (other than ivory and its products); sales of second-class medical devices; sales of disinfectants (excluding hazardous chemicals). (Except for projects subject to approval by law, independent business activities are carried out on the basis of a business license in accordance with the law).

Company Executives

  • Name
  • Position
  • Salary
  • ye jiang
  • Acting Chairman, Directors
  • --
  • peicheng wu
  • Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee
  • 80.00K
  • zhibo yin
  • Directors, VP, Chief Financial Officer, Strategy Committee Member
  • 1.00M
  • tao peng
  • Directors, Strategy Committee Member
  • 80.00K
  • yong li
  • Directors, Board Secretary, VP
  • 941.60K
  • xiaofang song
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 100.00K
  • yanlin ceng
  • Independent Directors, Chairman of the Nomination Committee, Strategy Committee Member
  • 41.70K
  • zeyang xu
  • Independent Directors, Audit Committee Member, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee
  • 100.00K
  • liping li
  • Securities Affairs Representative
  • --
  • qiujun lv
  • Chairman of the Supervisory Board, Auditors
  • 80.00K
  • zhenhua huang
  • Auditors
  • 50.00K
  • libin pan
  • Senior Advisors
  • 1.85M
  • yan chen
  • Employee Supervisors
  • 212.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data